Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database

References

• YonedaTHaginoHJapanese Allied Committee on Osteonecrosis of the Jaw, et al. Erratum to: Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the JawJ Bone Miner Metab20173512028120102
   PubMed Web of Science ®Google Scholar
• DodsonTBThe frequency of medication-related osteonecrosis of the jaw and its associated risk factorsOral Maxillofac Surg Clin North Am201527450951626362367
   PubMed Web of Science ®Google Scholar
• KhoslaSBurrDCauleyJBisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral ResearchJ Bone Miner Res200722101479149117663640
   PubMed Web of Science ®Google Scholar
• MarxREPamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJ Oral Maxillofac Surg20036191115111712966493
   PubMed Web of Science ®Google Scholar
• MaxillofacialSAdvisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial SurgeonsAmerican Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jawsJ Oral Maxillofac Surg200765336937617307580
   PubMed Web of Science ®Google Scholar
• RogersMJCrockettJCCoxonFPMönkkönenJBiochemical and molecular mechanisms of action of bisphosphonatesBone2011491344121111853
   PubMed Web of Science ®Google Scholar
• EndoYKumamotoHNakamuraMUnderlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ)Biol Pharm Bull201740673975028566618
   PubMed Web of Science ®Google Scholar
• ChawlaSHenshawRSeegerLSafety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studyLancet Oncol201314990190823867211
   PubMed Web of Science ®Google Scholar
• BaronRFerrariSRussellRGDenosumab and bisphosphonates: different mechanisms of action and effectsBone201148467769221145999
   PubMed Web of Science ®Google Scholar
• SaadFBrownJEvan PoznakCIncidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesAnn Oncol20122351341134721986094
   PubMed Web of Science ®Google Scholar
• ZhangXHamadehISSongSOsteonecrosis of the jaw in the united states food and drug administration’s adverse event reporting system (faers)J Bone Miner Res201631233634026288087
   PubMed Web of Science ®Google Scholar
• Aragon-ChingJBNingYMChenCCHigher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agentsCancer Invest200927222122619235596
   PubMed Web of Science ®Google Scholar
• VahtsevanosKKyrgidisAVerrouELongitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jawJ Clin Oncol200927325356536219805682
   PubMed Web of Science ®Google Scholar
• SivolellaSLumachiFStelliniEFaveroLDenosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe diseaseAnticancer Res20133351793179723645723
   PubMed Web of Science ®Google Scholar
• GuarneriVMilesDRobertNBevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancerBreast Cancer Res Treat2010122118118820361252
   PubMed Web of Science ®Google Scholar
• MochizukiTYanoKIkariKEffects of denosumab treatment on bone mineral density and joint destruction in patients with rheumatoid arthritisJ Bone Miner Metab201836443143828681148
   PubMed Web of Science ®Google Scholar
• YueJGriffithJFXiaoFRepair of bone erosion in rheumatoid arthritis by denosumab: A high-resolution peripheral quantitative computed tomography studyArthritis Care Res201769811561163
   Web of Science ®Google Scholar
• StopeckATLiptonABodyJJDenosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind studyJ Clin Oncol201028355132513921060033
   PubMed Web of Science ®Google Scholar
• JeongHGHwangJJLeeJHKimYHNaJYHanSSRisk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonatesImaging Sci Dent2017471455028361029
   PubMed Web of Science ®Google Scholar
• DimopoulosMAKastritisEBamiaCReduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acidAnn Oncol200920111712018689864
   PubMed Web of Science ®Google Scholar
• RipamontiCIManiezzoMCampaTDecreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of MilanAnn Oncol2009201137145
   PubMed Web of Science ®Google Scholar
• FuscoVGalassiCBerrutiADecreasing frequency of osteonecrosis of the jaw in cancer and myeloma patients treated with bisphosphonates: the experience of the oncology network of piedmont and aosta valley (north-Western Italy)ISRN Oncol2013201367202723533811
   PubMedGoogle Scholar
• van PuijenbroekEPBateALeufkensHGLindquistMOrreREgbertsACA comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiol Drug Saf200211131011998548
   PubMed Web of Science ®Google Scholar
• HatahiraHAbeJHaneYDrug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databasesJ Pharm Health Care Sci201731928729910
   PubMed Web of Science ®Google Scholar